报告内容概要： 藻酸盐敷料是以褐藻（如海带）提取的海藻酸钙纤维制成的医用敷料，属于第二类医疗器械，主要成分为藻酸盐。通过湿法纺丝工艺加工成无纺布或海绵形 态，部分产品添加银离子、氯化钙等功能性成分以增强止血、抗菌效果。该敷料接触伤口渗出液后形成凝胶，维持湿润环境并促进愈合，具有高吸湿性（可 吸收自身重量17-20倍液体），适用于褥疮、糖尿病足溃疡、烧伤等慢性渗出性伤口。藻酸盐敷料生产工艺包括湿法纺丝、水洗、牵伸及定型等工序，产品 形态涵盖片状、条状。其应用范围从手术止血敷料扩展至慢性创面护理，使用时需根据渗出量每1-3天更换，单次覆盖不超过7天。藻酸盐敷料按照规格主要 分为片状和条状，片状主要用于表浅伤口的治疗，而条状可以用于腔洞伤口、潜行和窦道等的治疗，由于其可以很容易地贴合伤口，因此可以用于各种形状 的伤口和各个解剖部位的伤口。数据显示，中国藻酸盐敷料行业市场规模从2017年的3.35亿元增长至2024年的34.21亿元，年复合增长率为39.37%。2025年 中国藻酸盐敷料行业市场规模约为37.83亿元。这一高速增长主要源于多重因素：人口老龄化加剧（2025年60岁以上人口占比达23%）直接推动慢性病患 ...

Core Insights - The core viewpoint of the article highlights the rapid growth and increasing adoption of alginate dressings in the medical field due to their superior properties such as high absorbency, breathability, and antibacterial effects, making them a preferred choice for wound care, especially for complex wounds like burns and ulcers [1][12]. Industry Overview - The alginate dressing industry in China has seen its market size grow from 335 million yuan in 2017 to an estimated 3.421 billion yuan by 2024, with a compound annual growth rate (CAGR) of 39.37% [1][12]. - By 2025, the market size is projected to reach approximately 3.783 billion yuan [1][12]. - Key growth drivers include an aging population, increased health awareness, advancements in medical technology, and a growing preference for biodegradable materials [1][12]. Industry Development History - The alginate dressing industry in China began in the late 1980s, initially dominated by traditional gauze and cotton pads [7]. - The introduction of alginate dressings was facilitated by foreign companies in the early 1990s, but market penetration remained low due to high costs and limited clinical awareness [7]. - Domestic companies have since made significant technological advancements, overcoming key production challenges [7]. Industry Supply Chain - The supply chain for alginate dressings includes upstream raw materials such as alginate, silver ions, calcium chloride, and collagen [9]. - The midstream involves the production and manufacturing of alginate dressings, while the downstream encompasses sales channels including pharmaceutical companies, hospitals, pharmacies, and e-commerce platforms [9]. Competitive Landscape - The competitive landscape features both domestic and foreign companies, with foreign firms like ConvaTec and Smith & Nephew holding significant market shares in high-end products [12]. - Domestic companies such as Ma Ying Long, Weigao Group, and Steady Medical are actively pursuing technological innovation and market expansion [12]. Industry Trends - The industry is expected to see a shift towards smart and functional products, integrating technologies like pH monitoring and drug release systems to enhance treatment precision [16]. - Demand is anticipated to grow in chronic wound management and high-end care scenarios, driven by rising chronic disease rates and the expanding medical aesthetics market [17]. - Future products will focus on low allergenicity, biocompatibility, and ease of use to cater to sensitive skin and complex wound needs [19].